Companies’ work part of a long-term commitment to diversifying clinical trials and expanding access to precision diagnostics globally
PALO ALTO, Calif. & ACCRA, Ghana–(BUSINESS WIRE)–Lucence, a precision oncology company using liquid biopsy to bring clarity to cancer care, and Yemaachi Biotech, a cancer research company based in Accra, Ghana, announced today that they are collaborating on a study to better characterize and understand the genomics of breast cancer in women of African descent.
Read the full press release here.
Image credits: www.lucence.com